Periampullary Cancer ESPAC-3(v2) trial: a Randomised Controlled Phase III Trial of Adjuvant Chemotherapy Versus Observation in Patients With Periampullary Adenocarcinomas of the Head of the Pancreas
Main Authors: | Neoptolemos, J, Moore, M, Cox, T, Valle, J, Palmer, D, Mcdonald, A, Carter, R, Tebbutt, N, Dervenis, C, Smith, D, Glimelius, B, Coxon, F, Lacaine, F, Middleton, M, Ghaneh, P, Bassi, C, Halloran, C, Olah, A, Rawcliffe, C, Buechler, M |
---|---|
Format: | Journal article |
Published: |
2011
|
Similar Items
-
Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
by: Neoptolemos, J, et al.
Published: (2012) -
EXPERIENCE OF SURGICAL TREATMENT OF TUMORS OF PANCREAS AND PERIAMPULLARY ZONE
by: A. N. Sidorov, et al.
Published: (2012-07-01) -
EMR of large periampullary neuroendocrine tumor
by: Eric M. Nelsen, MD, et al.
Published: (2017-12-01) -
Imaging of Ampullary and Periampullary Conditions
by: Abhijit Sunnapwar, et al.
Published: (2021-05-01) -
Malignant tumors of the periampullary region
by: Michael N Okobia, et al.
Published: (2001-01-01)